Ebitda Изменить Дата
Acadia Pharmaceuticals USD 40.99M 42.62M 2026-06
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
Amarin USD 12.54M 28.57M 2025-06
Amgen USD 5.8B 1.25B 2026-09
Arrowhead Research USD -147.68M 40.33M 2026-06
AstraZeneca USD 7.46B 2.3B 2026-09
Biogen USD 450.8M 198.9M 2026-06
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Eli Lilly USD 9.46B 3.54B 2026-09
Galectin Therapeutics USD -7.42M 819K 2021-12
Gilead Sciences USD -9.31B 12.82B 2026-06
GlaxoSmithKline GBP 3.51B 734M 2026-06
Incyte USD 778.57M 410.6M 2026-06
Ionis Pharmaceuticals USD -95.22M 9.99M 2026-09
Moderna USD -687M 571M 2026-06
Neurocrine Biosciences USD 375.3M 185.4M 2026-09
Novartis USD 8.62B 2.14B 2026-09
PTC Therapeutics USD 161.9M 99.92M 2026-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Sarepta Therapeutics USD -3.14M 33.31M 2026-09
Vertex Pharmaceuticals USD 888.6M 436.6M 2026-09